IM Cannabis (NASDAQ:IMCC) vs. Ascend Wellness (OTC:AAWH) Head to Head Contrast

IM Cannabis (NASDAQ:IMCCGet Rating) and Ascend Wellness (OTC:AAWHGet Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

Earnings and Valuation

This table compares IM Cannabis and Ascend Wellness’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IM Cannabis $43.32 million 1.59 -$14.17 million ($0.61) -1.62
Ascend Wellness $332.38 million 1.56 -$122.66 million N/A N/A

IM Cannabis has higher earnings, but lower revenue than Ascend Wellness.

Analyst Recommendations

This is a summary of recent ratings and price targets for IM Cannabis and Ascend Wellness, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IM Cannabis 0 0 3 0 3.00
Ascend Wellness 0 0 2 0 3.00

IM Cannabis currently has a consensus price target of $8.42, indicating a potential upside of 750.17%. Ascend Wellness has a consensus price target of $9.00, indicating a potential upside of 200.00%. Given IM Cannabis’ higher probable upside, research analysts clearly believe IM Cannabis is more favorable than Ascend Wellness.

Insider & Institutional Ownership

18.4% of IM Cannabis shares are owned by institutional investors. Comparatively, 0.0% of Ascend Wellness shares are owned by institutional investors. 5.9% of IM Cannabis shares are owned by company insiders. Comparatively, 24.9% of Ascend Wellness shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares IM Cannabis and Ascend Wellness’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IM Cannabis -44.71% -16.28% -11.82%
Ascend Wellness -29.10% -48.74% -12.62%

Summary

IM Cannabis beats Ascend Wellness on 7 of the 10 factors compared between the two stocks.

About IM Cannabis (Get Rating)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

About Ascend Wellness (Get Rating)

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations. It also sells its products to third-party licensed cannabis retail stores. The company was incorporated in 2018 and is headquartered in New York, New York.

Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.